Abstract:Through DNA microarray analysis and quantitative PCR verification, we have identified additional IL-17A-inducible genes-IL-19, CXCL-1, -2, -3, -5, and -6-in well-differentiated normal human bronchial epithelial cells. These genes, similar to previously described human beta-defensin-2 (HBD-2) and CCL-20, were induced by a basolateral treatment of IL-17A, and regulated by PI3K signaling and NF-kappaB activation. For PI3K signaling, increases of cellular PIP(3) and phosphorylation of downstream molecules, such as Akt and glycogen synthase kinase-3beta (GSK3beta) (S9), were detected. Induced gene expression and HBD-2 promoter activity were attenuated by LY294002, p110alpha small-interfering RNA (siRNA), as well as by an overexpression of constitutively active GSK3beta(S9A) or wild-type phosphatase and tensin homolog. Increased phosphorylation of JAK1/2 after IL-17A treatment was detected in primary normal human bronchial epithelium cells. Transfected siRNAs of JAK molecules and JAK inhibitor I decreased IL-17A-induced gene expression and GSK3beta(S9) phosphorylation. However, both JAK inhibitor I and PI3K inhibitor had no effect on the DNA-binding activities of p65 and p50 to NF-kappaB consensus sequences. This result suggested a JAK-associated PI3K signaling axis is independent from NF-kappaB activation. With siRNA to knockdown STIR (similar expression to fibroblast growth factor and IL-17R; Toll-IL-1R)-related signaling molecules, such as Act1, TNFR-associated factor 6 (TRAF6), and TGF-beta-activated kinase 1 (TAK1), and transfection of A52R, an inhibitor of the MyD88/TRAF6 complex, or dominant-negative TAK1, IL-17A-inducible gene expression and HBD-2 promoter activity were reduced. Additionally, IL-17A-induced p65 and p50 NF-kappaB activations were confirmed and their nuclear translocations were down-regulated by siRNAs of TRAF6 and TAK1. These results suggest that two independent and indispensable signaling pathways-1) JAK1-associated PI3K signaling and 2) Act1/TRAF6/TAK1-mediated NF-kappaB activation-are stimulated by IL-17A to regulate gene induction in human airway epithelial cells.

Identification and Functional Characterization of A Novel Interleukin 17 Receptor: A Possible Mitogenic Activation Through Ras/Mitogen-Activated Protein Kinase Signaling Pathway

Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.

Prokaryotic Expression, Purification and Bioactivity of Recombinant Mouse Interleukin 17f/his Fusion Protein

Construction and Identification of Retro Viral Vector Expressing Human Interleukin-17 Gene

Structural basis of interleukin-17B receptor in complex with a neutralizing antibody for guiding humanization and affinity maturation

Eukaryotic expression of the human interleukin 17F(hIL-17F) and its inducing effect on inflamation

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

Interleukin 1 Type 1 Receptor Restore: A Genetic Mouse Model for Studying Interleukin 1 Receptor-Mediated Effects in Specific Cell Types

A Novel IL-17 Signaling Pathway Controlling Keratinocyte Proliferation and Tumorigenesis Via the TRAF4–ERK5 Axis

[Eukaryotic Expression of Human IL17-RD-ECD and Generation of Its Monoclonal Antibody].

Prokaryotic Expression of Mouse Interleukin 17A and Its Ability of Stimulating RAW264.7 Cell Inflammatory Factors Expression

IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling

Molecular cloning, expression and biological activity of rhesus macaque interleukin-17A and interleukin-17F

IL-13Rα2 As a Functional Receptor Mediates Signal Transduction

Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells

Recombinant expression of human IL-17F fusion protein in E.coli and the study on its biological activity in vitro

Identification of a Novel Ligand-Receptor Pair Constitutively Activated by Ras Oncogenes

Establishment of IL-17A/F BAC construct for transgenic reporter mice

Interleukin-17F Signaling Requires Ubiquitination of Interleukin-17 Receptor Via TRAF6.

Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis

IL-17A Promotes the Migration and Invasiveness of Colorectal Cancer Cells Through NF-κB-Mediated MMP Expression